A4 Amyloid Beta Dosage & Reconstitution Guide
Research and educational use only — not medical advice, and not for human consumption. The figures below are summarized from public sources, product labeling, and community reports, and are not a prescription or a substitute for a qualified clinician.
Dosing guide
| Level | Dose | Notes |
|---|---|---|
| Omega-3 trial | 1700 | 1.7 g DHA + 0.6 g EPA daily in the referenced study |
Timing & cycling
This is not a peptide you take — it is the amyloid-beta target of Alzheimer's research. The dosing that exists is for the interventions studied around it.
Cycle length. Not applicable.
Storage & handling
Store capsules or powder in a cool, dry, dark place, tightly closed. Follow the product's own expiry date.
Key points
- Amyloid-beta is a disease target, not a supplement — the numbers here come from the nutritional interventions studied against it.
- Anyone acting on cognitive concerns needs a clinician, not a research-chemical vial.
What to monitor
Cognitive and biomarker endpoints belong in a clinical setting; there is nothing to self-dose here.
Legal & prescription status
No — this is a laboratory research reagent, not a therapeutic. There is no approved or prescription form intended for human administration.
References
This guide is for research and educational purposes only. It is not medical advice and does not describe a product approved for human use. Always consult a qualified healthcare professional before considering any peptide protocol.